Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

STOX1 Activators

Storkhead box 1 (STOX1) is a member of the forkhead family of transcription factors, characterized by a distinct DNA-binding domain known as the forkhead box, or FOX. The STOX1 protein contains this winged-helix domain responsible for binding to specific DNA sequences, thus regulating the expression of target genes.The "storkhead" designation in the name implies a unique structure within the forkhead domain, which influences the protein's DNA-binding specificity and function. Transcription factors like STOX1 are critical for controlling numerous cellular processes, including development, differentiation, proliferation, apoptosis, and response to stress.

STOX1 has been particularly studied in the context of human health for its association with pre-eclampsia, a complex pregnancy disorder characterized by high blood pressure and damage to another organ system, often the kidneys. Genetic studies have linked variations in the STOX1 gene with an increased risk of developing pre-eclampsia, suggesting that it plays a role in placental development and function. The exact mechanisms by which STOX1 contributes to this condition are not entirely understood, but it may involve dysregulation of genes that control trophoblast proliferation and invasion-key processes in the establishment of a healthy placenta.Apart from its implicated role in pre-eclampsia, STOX1 may also be involved in other physiological and pathological processes given its function as a transcription factor. However, much of its broader biological roles remain to be fully elucidated.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that alters gene expression, possibly affecting STOX1 activity by epigenetic modulation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

An inhibitor of histone deacetylases (HDACs), which may influence STOX1 activity through epigenetic changes affecting chromatin structure and gene expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An inhibitor of MEK, a kinase in the MAPK pathway, potentially affecting STOX1 activity through altered cellular signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor, which may influence STOX1 by modulating the PI3K/Akt pathway, impacting various cellular processes including transcriptional regulation.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

An inhibitor of the TGF-β receptor, potentially influencing STOX1 activity through the TGF-β signaling pathway.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

A ROCK inhibitor, which may affect STOX1 activity by modulating cytoskeletal dynamics and related signaling pathways.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels, which could indirectly influence STOX1 activity by modulating cellular signaling.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

An HSP90 inhibitor, which may affect STOX1 activity by influencing the stability and function of various client proteins.

Histone Lysine Methyltransferase Inhibitor Inhibitor

935693-62-2 (free base)sc-202651
5 mg
$151.00
4
(1)

An inhibitor of G9a histone methyltransferase, potentially affecting STOX1 activity through epigenetic modulation of chromatin.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which may influence STOX1 activity by altering stress response and apoptotic signaling pathways.